Hemorrhagic and Thrombotic Abnormalities of Cancer

Lee Schwartzberg, James M. Holbert

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Complications arising from bleeding dyscrasias and throm¬botic events remain important causes of mortality and mor¬bidity in cancer patients. Abnormalities of hemostasis are extremely common in this patient population. The risk of hemostatic defects differs according to the type of under¬lying malignancy and the treatment given. In the intensive care setting, cancer patients have multiple reasons for hem-orrhagic complications, including massive transfusions, sep¬sis, chemotherapy and drug effects, and direct organ im¬pairment of the liver, kidney, and bone marrow by malignant cell infiltration.

Original languageEnglish (US)
Pages (from-to)107-128
Number of pages22
JournalCritical Care Clinics
Volume4
Issue number1
DOIs
StatePublished - Jan 1 1988

Fingerprint

Neoplasms
Hemostatics
Critical Care
Hemostasis
Bone Marrow Cells
Sepsis
Hemorrhage
Morbidity
Kidney
Drug Therapy
Mortality
Liver
Pharmaceutical Preparations
Population
Therapeutics

All Science Journal Classification (ASJC) codes

  • Critical Care and Intensive Care Medicine

Cite this

Hemorrhagic and Thrombotic Abnormalities of Cancer. / Schwartzberg, Lee; Holbert, James M.

In: Critical Care Clinics, Vol. 4, No. 1, 01.01.1988, p. 107-128.

Research output: Contribution to journalArticle

Schwartzberg, Lee ; Holbert, James M. / Hemorrhagic and Thrombotic Abnormalities of Cancer. In: Critical Care Clinics. 1988 ; Vol. 4, No. 1. pp. 107-128.
@article{e64255aa6cfe4976bfaf810eb562ddf6,
title = "Hemorrhagic and Thrombotic Abnormalities of Cancer",
abstract = "Complications arising from bleeding dyscrasias and throm¬botic events remain important causes of mortality and mor¬bidity in cancer patients. Abnormalities of hemostasis are extremely common in this patient population. The risk of hemostatic defects differs according to the type of under¬lying malignancy and the treatment given. In the intensive care setting, cancer patients have multiple reasons for hem-orrhagic complications, including massive transfusions, sep¬sis, chemotherapy and drug effects, and direct organ im¬pairment of the liver, kidney, and bone marrow by malignant cell infiltration.",
author = "Lee Schwartzberg and Holbert, {James M.}",
year = "1988",
month = "1",
day = "1",
doi = "10.1016/S0749-0704(18)30507-4",
language = "English (US)",
volume = "4",
pages = "107--128",
journal = "Critical Care Clinics",
issn = "0749-0704",
publisher = "W.B. Saunders Ltd",
number = "1",

}

TY - JOUR

T1 - Hemorrhagic and Thrombotic Abnormalities of Cancer

AU - Schwartzberg, Lee

AU - Holbert, James M.

PY - 1988/1/1

Y1 - 1988/1/1

N2 - Complications arising from bleeding dyscrasias and throm¬botic events remain important causes of mortality and mor¬bidity in cancer patients. Abnormalities of hemostasis are extremely common in this patient population. The risk of hemostatic defects differs according to the type of under¬lying malignancy and the treatment given. In the intensive care setting, cancer patients have multiple reasons for hem-orrhagic complications, including massive transfusions, sep¬sis, chemotherapy and drug effects, and direct organ im¬pairment of the liver, kidney, and bone marrow by malignant cell infiltration.

AB - Complications arising from bleeding dyscrasias and throm¬botic events remain important causes of mortality and mor¬bidity in cancer patients. Abnormalities of hemostasis are extremely common in this patient population. The risk of hemostatic defects differs according to the type of under¬lying malignancy and the treatment given. In the intensive care setting, cancer patients have multiple reasons for hem-orrhagic complications, including massive transfusions, sep¬sis, chemotherapy and drug effects, and direct organ im¬pairment of the liver, kidney, and bone marrow by malignant cell infiltration.

UR - http://www.scopus.com/inward/record.url?scp=0023880113&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023880113&partnerID=8YFLogxK

U2 - 10.1016/S0749-0704(18)30507-4

DO - 10.1016/S0749-0704(18)30507-4

M3 - Article

VL - 4

SP - 107

EP - 128

JO - Critical Care Clinics

JF - Critical Care Clinics

SN - 0749-0704

IS - 1

ER -